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Abstract 
 
The pathophysiology of aortic dissection is poorly understood and its risk is resistant to 
medical treatment. Most studies have focused on a proposed pathogenic role of 
transforming growth factor (TGF)-β in Marfan disease and related Thoracic Aortic 
Aneurysms and Aortic Dissections (TAADs). However, clinical testing of this concept 
using angiotensin II type 1 receptor antagonists to block TGF-β signaling fell short of 
promise. Genetic mutations that predispose to TAADs affect components of the 
extracellular matrix (ECM) and proteins involved in cellular force generation. Thus, a 
role for dysfunctional mechanosensing in abnormal aortic wall remodeling is emerging. 
However, how abnormal mechanosensing leads to aortic dissection remains a mystery. 
Here, we review current knowledge about the regulation of interstitial fluid dynamics and 
myogenic tone, and propose that alteration in contractile force reduces vascular tone in 
the microcirculation (here, aortic vasa vasorum), and leads to elevations of blood flow, 
transmural pressure and fluid flux into the surrounding aortic media. Furthermore, 
reduced contractile force in medial smooth muscle cells coupled with alteration of 
structural components of the ECM limits ECM contraction, further promoting the 
formation of intramural edema, a critical step in the initiation of aortic dissection. The 
concept is supported by several pathophysiological and clinical observations. A direct 
implication of this concept is that drugs that lower blood pressure and limit interstitial 
fluid accumulation while preserving or increasing microvascular tone would limit the risk 
of dissection. In contrast, drugs that substantially lower microvascular tone would be 
ineffective, or may accelerate the disease and precipitate aortic dissection.  
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List of abbreviations: 
 
ECM: Extracellular matrix 
GAGs: Glycosaminoglycans 
MT: Myogenic tone  
Pif: Interstitial fluid pressure 
SMC: Smooth muscle cell 
TAAD: Thoracic Aortic Aneurysms and Aortic Dissections 
TGF: Transforming growth factor 
TRP: Transient receptor potential   
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Genetic mutations that predispose to TAADs affect structural components of the ECM, 
transmembrane structures involved in mechanical integrity, mechanosensing and signal 
transduction, or intracellular components of the cell contractile apparatus 1-3. Concepts 
and studies are being developed to explain how such alterations may impact the 
response of the aorta to hemodynamic stress and drive abnormal aortic remodeling 4. 
Here, we propose a focus shift towards the small vessels (arterioles and vasa vasorum) 
to explain, based on current knowledge about the (patho)physiology of blood flow 
regulation and fluid dynamics, how alterations in ECM and the cell contractile apparatus 
may instigate the frightening process of aortic dissection. 
 
Microcirculatory vascular tone and the autoregulation of blood flow: the example 
of myogenic tone  
Microcirculatory vascular tone is the main determinant of vascular resistance, and 
ensures tissue perfusion in response to changing metabolic demands. An increase in 
pressure induces a rapid and reversible vasoconstriction of small r sistance vessels, an 
intrinsic property due to their ability to develop myogenic tone (MT)5. Besides protecting 
downstream capillaries from abrupt increases in blood pressure occurring in larger 
vessels, MT has a key role in the inward eutrophic vascular remodeling in response to a 
chronic rise in pressure.  
 
Pressure induces deformation of cell membrane proteins such as stretch-activated ion 
channels; conformational changes in matrix and cytoskeletal proteins; activation of ECM 
and integrins, as well as activation of various cellular junctions (Figure 1). Vascular 
smooth muscle cell (SMC) depolarization and calcium entry are necessary for the 
development of pressure-induced contraction and myogenic tone. Although the nature 
of the channel(s) involved in MT development remains debated, canonical transient 
receptor potential (TRP) channels are strong candidates. Interactions of TRP Polycystin 
1 and 2 (TRPP1 and TRPP2) with filamin A, an actin crosslinking protein, are critical for 
stretch-activated ion channel regulation and MT development6. Indirect evidence for a 
role of chloride channels in MT has also been suggested 7. G-protein coupled receptors 
like the angiotensin type 1 receptor possess mechanosensitive properties, independent 
of ligand binding, and may activate TRPs5, 8. Recent studies also showed that 
interactions between SMCs and ECM are involved in MT. Pressure-induced 
deformation of ECM elements may activate integrins (e.g., β1, β3)9, and induces 
cytoskeletal remodeling and contraction through modulation of stretch-activated ion 
channel/TRP and membrane depolarization10. Calcium sensitization of the contractile 
apparatus through RhoA/Rho-kinase and actomyosin crossbridge cycling allows force 
maintenance without high intracellular calcium concentration5. In addition to vascular 
SMCs, pericyte constriction in pre-capillaries involves similar transduction pathways and 
may play a significant role in the regulation of tissue perfusion11. 
 
 
Interstitial fluid pressure 
Transcapillary fluid flux is also highly controlled by the level of interstitial fluid pressure 
(Pif) exerted on the outside of the capillaries. A reduction of Pif promotes and maintains 
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edema formation (Figure 2). Composition and functional properties of the ECM are 
major determinants of the level of Pif 12, 13. Briefly, polyanionic glycosaminoglycans 
(GAGs) of the ECM are osmotically active, whereas collagens, elastic fibers and 
microfibrils play important roles in ECM contraction and oppose the decrease of Pif. In 
steady state, GAGs are under-hydrated. When fluid gains access to the interstitial 
space, the osmotically active GAGs absorb water molecules and swell, which tends to 
limit the increase of Pif due to an increase of interstitial volume. This phenomenon 
sustains edema formation. In that case, opposing contraction of the interstitium, driven 
by the physical properties of the microfibril/collagen network and force generation by its 
cellular constituents, plays a critical balancing effect and limits edema formation 
(reviewed in 12, 13).  
 
Genes associated with TAADs are involved in the regulation of microvascular 
tone and interstitial fluid pressure 
Microvascular tone: Genetic mutations that predispose to TAADs affect components of 
the ECM and proteins involved in cellular force generation1. It is quite remarkable that 
many of those pathways are involved in the regulation of microvascular tone. This is the 
case of mutations altering pressure sensing (filamin A FLNA, and polycystins PDK1 and 
PKD2), or mutations altering SMC contraction (myosin light chain kinase MYLK). Other 
pathways/genes involved in TAADs are expected to alter microvascular tone. This is the 
case of ACTA2 (actin alpha 2, smooth muscle) and MYH11 (myosin heavy chain 11, 
smooth muscle), which are involved in SMC contraction; gain-of-function mutation in 
PRKG1 (protein kinase, cGMP-dependent, type I, involved in SMC relaxation), or 
mutations in PLOD1 (procollagen-lysin, 2-oxoglutarate 5-dioxygenase 1, associated 
with severe muscle hypotonia). Mutations in TGFB2, TGFBR1, TGFBR2 and SMAD3, 
which are associated with Loeys-Dietz syndrome, do not increase but rather limit TGF-β 
signaling in vitro14. In that regard, it is interesting to note that TGF-β activity regulates 
the arteriolar myogenic response15, suggesting that reduced TGF-β signaling in Loeys-
Dietz syndrome may impair microcirculatory tone. Other TAAD-related mutations 
affecting ECM components (e.g., COL3A1) have not been related directly to alteration 
of vascular tone. However, it is intriguing to note that COL3A1 may couple GPR56, an 
atypical G-protein coupled receptor, to the Gαq12/13 family of G proteins and may 
activate RhoA16, a prominent pathway with essential role in the generation of vascular 
tone. 
 
Interstitial fluid pressure: As summarized above, given the major roles of 
microfibril/collagen network in the regulation of Pif 12, 13, both direct (fibrillin-1 FBN1 in 
Marfan syndrome, collagen type III A 1 COL3A1 in Ehlers-Danlos syndrome, collagen 
type III A1 COL1A, etc.) and indirect (genes involved in TGF-β signaling) alterations of 
ECM components are expected to alter Pif. Depending on the context, both β1 and β3 
integrins may modulate the generation and maintenance of Pif 17, 18. Contraction of 
connective tissue is also modulated through force generation by its cellular components. 
Therefore, alteration in force generation (e.g., MYLK) may significantly impair Pif. 
Intriguingly, recent data indicate that TGF-β activity also regulates aldosterone levels, 
and sodium and water retention19, suggesting that reduced TGF-β signaling in Loeys-
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Dietz syndrome or inhibition of TGF-β signaling in Marfan, may both impair 
microvascular tone and promote interstitial fluid accumulation. 
 
Alteration of microvascular tone and interstitial pressure as major determinants 
of aortic dissection  
Based on this knowledge, we propose that a decrease of vascular tone (intrinsic or 
iatrogenic) upstream of or within the aortic vasa vasorum will lead to alteration of blood 
flow regulation and increased transmural pressure, which will promote the development 
of intra-parietal (adventitial and medial) edema (and potentially hemorrhage, dependent 
on the degree of alteration of microvessel integrity), which will instigate the process of 
aortic dissection. Any associated alteration of ECM that prevents an increase of Pif will 
further promote and sustain intramural edema. Additional alterations in draining 
lymphatics 20 (including reduced myogenic tone 21 or abnormal pulse transfer 22) or in 
force components controlling transcapillary fluid flux 23, 24 will act as aggravating factors. 
Finally, alterations in endothelial cells and glycocalyx (as it may be the case at 
branching arterial sites or in areas of low shear stress) would alter vessel permeability 
and increase the porosity and hydration of the medial interstitium, particularly in 
response to increased intravascular pressure 25-28, and would further promote interstitial 
edema formation.  
 
Pathophysiological predictions of the model 
Aortic dissection is believed to originate with a tear in the intima 29-31. However, a true 
intimal rupture may be absent in a substantial percentage of aortic dissections.  
Given that vasa vasorum only penetrate the outer third of the thoracic aortic media32, 
the model presented here predicts that a large percentage if not most aortic dissections 
in humans will start by the formation of an intramural edema and a small tear in the 
outer third of the media. Recurrence and coalescence of small medial tears will 
eventually induce aortic medial delamination, which may culminate in the formation of a 
false channel if the tear reaches the intima.  
This hypothesis is supported by the presence of leaky neovessels in the media of 
human TAADs33 and by recent extensive histopathological analyses showing that most 
(20 out of 21) aortic tears originate in the outer third of the media alongside the vasa 
vasorum34. 
 
The model also provides an intriguing explanation for the detection of foci of GAGs in 
the outer media of diseased aortas, which are considered to induce significant stress 
concentrations and intra-lamellar Donnan swelling pressures 35, 36. The mechanism 
behind increased detection of GAGs is unknown, but the current paradigm refers to 
increased GAG production 37, 38. The model presented here suggests an additional or 
alternative mechanism whereby access of fluid to the interstitial space (secondary to 
alteration of microvascular tone and Pif) will inevitably induce swelling of the osmotically 
active and under-hydrated GAGs, leading to expansion of the vessel area occupied by 
GAGs. This would limit the increase of Pif (particularly in case of abnormal 
microfibril/collagen network) and would alter stress transfer within the aortic wall, 
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potentially initiating a vicious circle. It is also interesting to note that GAGs may 
modulate local generation of several active modulators of capillary leakage 39. 
Since vasa vasorum are normally absent from the human abdominal aortic media 40, a 
further implication of the model is that medial dissection would be a rare event in the 
human abdominal aorta, a prediction supported by ample clinical observation. However, 
adventitial remodeling (with abnormal lymphatic drainage, inflammatory changes and 
neoangiogenesis) may become more prominent in the latter setting 41, 42. This would 
also apply to aortas of small animals (e.g., rodents) where we propose that additional 
factors (e.g., hypertension 43, increased sodium/chloride and water reabsorption 43-45, 
and abnormal endothelial function 25, 26) may combine together to ultimately increase 
interstitial fluid retention in adventitia and outer media, the major process that would 
instigate aortic dissection.  
 
Clinical predictions and implications of the model 
A potential power of the model is its suitability to pre-clinical and clinical testing.  
A recent study showed that pressure-induced intramural delamination was associated 
with accumulation of interstitial fluid in aortic media of mice with disrupted TGF-β 
signaling, and could be prevented in part by pharmacologic improvement of SMC 
contractility ex vivo46. The results are consistent with the present hypothesis on the role 
of ECM contraction in limiting interstitial fluid retention and delamination. However, 
further studies are needed to examine whether the same results may apply to sub-
vessel level SMC contraction in human thoracic aorta. 
 
A major direct implication of the model relates to its potential to predict the effectiveness 
of medical strategies in patients with TAADs. According to the hypothesis presented 
here, drugs that lower blood pressure while preserving or increasing microvascular tone 
and Pif would limit the occurrence of aortic dissection. In contrast, drugs that further 
lower microvascular tone and Pif or promote interstitial fluid accumulation would be 
ineffective or may even precipitate aortic dissection. 
As such, the model may support the effectiveness of beta-blockers in reducing aortic 
root dilatation in patients with Marfan syndrome 47, 48 and suggests that they could be 
useful in limiting vascular complications in other TAADs. Interestingly, a recent pilot trial 
reported a protective effect of beta-blockers in patients with Ehlers Danlos syndrome 49.  
In contrast, the model predicts that calcium channel blockers, which substantially inhibit 
myogenic tone, would be ineffective or might accelerate disease progression and aortic 
dissection in TAADs. This hypothesis merits serious consideration. Interestingly, the 
results of a recent observational and retrospective study by Doyle et al. suggest that the 
use of calcium channel blockers in patients with Marfan syndrome and other forms of 
TAADs may be associated with increased risk of aortic dissection and need for surgery, 
in comparison with the use of other antihypertensive agents50. Following a series of 
mechanistic experimental studies in Marfan mice, Doyle et al. attributed the increased 
risk of aortic dissection to enhanced activation of protein kinase C beta pathway, and 
showed that the clinically available anti-hypertensive agent hydralazine both limited 
protein kinase C beta activation and normalized aortic growth in Marfan mice. This led 
the authors to consider hydralazine ‘an appealing alternative therapeutic strategy for 
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Marfan syndrome’50. In contrast, the model presented here does not support the use of 
hydralazine in the human setting of Marfan disease or other TAADs given the expected 
inhibitory effect of hydralazine on myogenic tone. Similarly, our model also suggests 
that the recent failure of losartan in Marfan patients 48, 51 may be due, at least in part, to 
the inhibitory effect of angiotensin type 1 receptor blockade on myogenic tone. Thus, we 
believe that modulation of blood pressure in TAAD patients should be considered in 
light of potential side effects that may result from excessive inhibition of myogenic tone. 
In the future, other pathways involved in maintenance of vascular integrity and 
regulation of vascular tone, e.g., selective sphingosine 1 phosphate signaling pathways 
52-55, may be worth of consideration as potential adjunctive therapeutic targets. 
 
Treatment with diuretics may limit the expansion of interstitial fluid and may constitute a 
therapeutic option. However, treatment with high-ceiling diuretics (e.g., bumetanide, 
furosemide) should be considered with caution, as they may reduce myogenic tone 
through inhibition of Na-K-Cl cotransporter (NKCC)1 56. Mineralocorticoid receptor 
antagonists (e.g., spironolactone, eplerenone) could also reduce NKCC1 activity and 
myogenic tone, although to a lower extent 57, 58. This is supported by the fact that 
selective deletion of mineralocorticoid receptor SMCs does not alter myogenic tone in 
adult young mice 59. An appropriate diuretic should therefore show a favorable profile 
between its beneficial effects on interstitial fluid accumulation and its potential 
deleterious impact on myogenic tone.  
Other strategies to modulate Pif may be worth of investigation. This could be achieved 
through modulation of interstitial volume, direct modulation of synthesis/degradation and 
functionality of ECM components (e.g., GAGs, integrins) or through the targeting of 
‘inflammatory’ mediators involved in edema formation (e.g., kinins, prostaglandins).  
 
Finally, the model may have implications or the development and use of new diagnostic 
technologies. For example, imaging modalities that accurately detect interstitial edema 
may be of additive value in predicting aortic disease progression and susceptibility to 
dissection. 
 
In conclusion, we propose that alterations of microvascular tone and interstitial pressure 
play a major role in the progression of TAADs and the initiation of aortic dissection. An 
effective therapeutic strategy should aim to limit hemodynamic stress on the large 
arterial conduit, reduce transcapillary fluid flux and interstitial fluid accumulation, while 
maintaining or increasing microvascular tone.  
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HIGHLIGHTS: 
 
• Genetic mutations that predispose to thoracic aortic aneurysms and aortic 
dissections affect components of the extracellular matrix and proteins involved in 
cellular force generation. 
• We propose that those alterations lead to reduced myogenic tone in vasa 
vasorum and defective regulation of interstitial fluid pressure in the aortic wall  
• Those events create increased accumulation of interstitial fluid, and induce intra-
lamellar swelling pressures and significant stress concentrations around foci of 
glycosaminoglycans, which may promote aortic wall delamination and dissection 
• Strategies that limit hemodynamic stress on the aortic wall, reduce transcapillary 
fluid flux and interstitial fluid accumulation, while maintaining or increasing 
myogenic tone, should be effective in the prevention of aortic dissection. 
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FIGURE LEGENDS 
 
Figure 1. Summary of the mechanism of myogenic tone with a focus on pathways 
associated with TAADs. 
In response to an increase in blood pressure (P), a resistance artery contracts in 
response to the activation of cationic influx through stretch-activated channels such as 
transient potential (TRP) channels, possibly TRPC. Pressure may activate several 
pathways, which may act simultaneously and/or synergistically. Beside the direct 
activation of TRP channels by pressure, the interaction of polycystin 1 and 2 (TRPP 1 
and 2) with filamin A and the actin cytoskeleton may induce TRP opening. TRP 
activation leads to Na+ and Ca2+ entry, membrane depolarization and contraction. 
Deformation of the extracellular matrix (ECM) by pressure may be transmitted to the 
integrins and the cytoskeleton and transmitted to the surrounding smooth muscle cells 
(SMC). Alternatively, pressure may also activate G protein-coupled receptor such as 
AT1R and subsequently stimulate TRP either directly or through phospholipase C (PLC) 
activation and diacylglycerol (DAG) production. DAG activates protein kinase C and 
SMC contraction. Phospholipase A2 (PLA2) has also been shown to play a role through 
the synthesis of 20-HETE from arachidonic acid (AA). Finally, activation of RhoA in 
association with caveolin-1 (Cav-1) and of Rho-kinase allows sensitization of the 
contractile apparatus to calcium with modulation of myosin light chain phosphorylation 
(pMLC) as a critical downstream event.  
 
Figure 2. Microcirculatory abnormalities and formation of intra-parietal edema at 
the origin of aortic dissection. Myogenic tone in vascular smooth muscle cells (SMC) 
and pericytes of small vessels and pre-capillaries limits the increase of flow and 
pressure in the vasa vasorum (VV). Collagen, elastic fibers and microfibrils of the 
connective tissue and their interactions with the medial SMC are critical for connective 
tissue ‘contraction’ and are important to maintain high interstitial fluid pressure (Pif). 
Genes/pathways associated with TAADs are involved in the generation of myogenic 
tone and Pif. We propose that alterations of microvascular tone and interstitial pressure 
generation would induce interstitial edema and swelling of the osmotically active 
glycosaminoglycans (GAGs), particularly in the presence of altered connective tissue. 
This would alter stress transfer and generate significant heterogeneities in stress 
concentration within the aortic wall, potentially initiating a vicious circle. Multiple 
contiguous foci of intra-parietal edema will eventually coalesce, leading to intra-parietal 
dissection. Alterations in lymphatic drainage (not depicted) may further aggravate 
interstitial edema and impact on vascular function (see main text). Parts of the scheme 
is adapted from reference 13. 
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